Cargando…
Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering
Statins induce plaque regression characterized by reduced macrophage content in humans, but the underlying mechanisms remain speculative. Studying the translational APOE*3-Leiden.CETP mouse model with a humanized lipoprotein metabolism, we find that systemic cholesterol lowering by oral atorvastatin...
Autores principales: | Härdtner, Carmen, Kornemann, Jan, Krebs, Katja, Ehlert, Carolin A., Jander, Alina, Zou, Jiadai, Starz, Christopher, Rauterberg, Simon, Sharipova, Diana, Dufner, Bianca, Hoppe, Natalie, Dederichs, Tsai-Sang, Willecke, Florian, Stachon, Peter, Heidt, Timo, Wolf, Dennis, von zur Mühlen, Constantin, Madl, Josef, Kohl, Peter, Kaeser, Rafael, Boettler, Tobias, Pieterman, Elsbeth J., Princen, Hans M. G., Ho-Tin-Noé, Benoît, Swirski, Filip K., Robbins, Clinton S., Bode, Christoph, Zirlik, Andreas, Hilgendorf, Ingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725697/ https://www.ncbi.nlm.nih.gov/pubmed/33296022 http://dx.doi.org/10.1007/s00395-020-00838-4 |
Ejemplares similares
-
Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice
por: Leipner, Julia, et al.
Publicado: (2021) -
Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression
por: Lindau, Alexandra, et al.
Publicado: (2016) -
Elevated platelet–leukocyte complexes are associated with, but dispensable for myocardial ischemia–reperfusion injury
por: Starz, Christopher, et al.
Publicado: (2022) -
Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice
por: Pennig, Jan, et al.
Publicado: (2019) -
CD40L Deficiency Attenuates Diet-Induced Adipose Tissue Inflammation by Impairing Immune Cell Accumulation and Production of Pathogenic IgG-Antibodies
por: Wolf, Dennis, et al.
Publicado: (2012)